Filing Flows › Enovix (ENVX) › R&D spending
Enovix (ENVX) R&D spending by quarter
Enovix's R&D spending was $24.4M in Q2 2026 (second quarter 2026), -8% from Q1 2026. Over the last 7 quarters it ranged from $22.4M (Q4 2024) to $28.2M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $24.4M | -8% | -13% |
| Q1 2026 | $26.5M | -6% | +2% |
| Q4 2025 | $28.1M | -0.4% | +25% |
| Q3 2025 | $28.2M | +0.1% | — |
| Q2 2025 | $28.1M | +9% | — |
| Q1 2025 | $25.9M | +16% | — |
| Q4 2024 | $22.4M | — | — |
Q2 2026 at a glance
Enovix, Q2 2026: revenue $9.0M (+21% year over year), operating margin -479.8%, net loss $43.1M, operating cash flow −$21.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Enovix's R&D spending?
Enovix's R&D spending was $24.4M in Q2 2026 (second quarter 2026), -8% from Q1 2026.
How has Enovix's R&D spending changed?
Over the last 7 quarters it ranged from $22.4M (Q4 2024) to $28.2M (Q3 2025).